Leap Therapeutics Rebrands as Cypherpunk Technologies After $50M Zcash Buy
Former oncology company Leap Therapeutics officially changed its name to Cypherpunk Technologies as part of a strategic pivot into digital assets. The firm closed a $58.9 million financing led by Winklevoss Capital earlier this month and signaled plans to convert a sizable portion of its balance sheet into crypto, including an approximately $50 million commitment to Zcash (ZEC). The move positions Cypherpunk as a digital treasury company focused on privacy-oriented assets.
This marks another example of a public company reallocating capital into crypto, and it could boost liquidity and market attention for ZEC while prompting closer scrutiny from investors and regulators. For crypto markets, the deal underscores growing corporate appetite for on-chain exposure and raises questions about governance, custody, and long-term treasury management as firms adopt privacy coins within their portfolios.